ProBackend
mental health
3 hours ago6 min read

Beyond the Symptom Checklist: How Bipolar Disorder and the Great Imitator Evaded Psychiatric Detection

An analysis of the dangers of symptom-checklist psychiatric diagnostics, highlighting a case of neurosyphilis and bipolar disorder misdiagnosed as MDD and GAD.

The Process Breakdown on Michigan Avenue

If you run a compliance audit on the office of a psychiatrist with 40 years of experience, you expect to find rigorous verification protocols. In 2016, sitting high above Michigan Avenue in Chicago, Dr. H's office looked exemplary. It was packed with books and small sculptures—the classic aesthetic of a practitioner who took the human psyche seriously. But behind the impressive skyline view and the shelf of academic literature lay a massive systemic failure.

When Patrick William Kelly, Ph.D., sat across from Dr. H, he was handed two clinical labels: major depressive disorder (MDD) and generalized anxiety disorder (GAD). Both diagnoses came straight from the Diagnostic and Statistical Manual of Mental Disorders (DSM). Both were delivered with the absolute certainty of a long career.

But they were wrong.

Kelly was constitutionally, almost aggressively, optimistic. For over three decades, he had never experienced prolonged depression. The DSM labels fit him like a coat cut for someone else's body. What Dr. H missed—and what the entire system missed for the next four years—was that Kelly was actually experiencing the depressive crash of an undiagnosed bipolar illness. At the very same time, a syphilis infection was quietly invading his central nervous system, mimicking psychiatric symptoms with eerie accuracy.

The intake was a failure of basic verification. The clinician took a checklist of subjective symptoms and declared it a complete diagnostic map. That is not science; it is a cataloging error.

The Process Breakdown on Michigan Avenue

Auditing the Great Imitator

In the world of infectious diseases, Treponema pallidum is known as "The Great Imitator." The World Health Organization and the Centers for Disease Control and Prevention have documented its ability to mimic everything from dermatological issues to cognitive decline. When it crosses the blood-brain barrier and becomes neurosyphilis, the bacteria cause anxiety, severe insomnia, cognitive fog, and extreme mood instability.

It rewrites the mind from the inside.

Yet, despite Kelly's personal history, nobody ordered a simple blood test. Over the course of four months, he was evaluated by four different hospital systems in addition to his outpatient psychiatrist. Not a single doctor ordered a comprehensive history and physical. Not a single clinic ordered an STD panel—even though Kelly was a gay man in a period of high-risk sexual behavior.

Think about the process breakdown. Every institution simply accepted the diagnosis of the previous clinic. They copied the labels onto new clipboards and signed off on the system change without any independent auditing. If a software engineer deployed code changes to production based solely on the word of a previous dev without running unit tests, they would be fired immediately. But in psychiatry, this lazy inheritance of unverified diagnoses is standard operating procedure. They were speaking serotonin therapy while the client's brain was literally on fire with an untreated bacterial infection.

Auditing the Great Imitator

The Polypharmacy Roulette Wheel

When the initial diagnosis is wrong, the treatment becomes a dangerous game of trial and error. Because Kelly did not improve on his initial prescriptions, his team spun the pharmaceutical roulette wheel. When trazodone failed, they added hydroxyzine. When that did nothing, they added seroquel—a heavy-duty atypical antipsychotic. Later, they threw Lexapro and Buspar into the mix.

In systems engineering, if a system is unstable, you do not keep adding uncalibrated feedback loops. That only increases the risk of a catastrophic crash. This practice is called polypharmacy, and it is a known systemic risk in modern mental healthcare.

The stakes were lethal. Antidepressants like Lexapro and trazodone are known to destabilize a bipolar brain. They act like a chemical catalyst, triggering the very manic and mixed states they are supposed to suppress. The brain is not a simple soup of mood chemicals; it is a physical network. In fact, bipolar disorder involves structural changes to the brain's white matter transmission lines, as detailed on Neuroscience of Bipolar Disorder: White Matter Networks. When you pump destabilizing antidepressants into a brain with these structural vulnerabilities, you are dumping rocket fuel onto a broken electrical grid. The prescriptions did not help him; they actively pushed him toward the edge.

The Overdose and the Post-Crisis Audit

The crash arrived four months after Kelly left Dr. H's office. He swallowed a toxic cocktail of trazodone, seroquel, Lexapro, and Buspar—the very instruments the system had prescribed to keep him alive. He fell into a six-day coma.

He almost died.

When the hospital finally ran a blood test in the aftermath, the syphilis diagnosis arrived like a cold, database alert. The physiological source of his symptoms was finally visible on a lab sheet.

But the system refused to run a post-mortem review. The psychiatric team that treated him for three weeks after his suicide attempt kept the blinkers on. They did not explore whether his history contained manic episodes. They did not adjust the GAD or MDD labels. His mother begged to be present during assessments to offer his history. They refused to let her in. They declined to interview his father. They discharged him with the exact same diagnostic codes and the exact same classes of medications that had nearly killed him.

This is a standard quality control failure. When an incident occurs in technology, you conduct a root-cause analysis and update your runbooks. You do not deploy the exact same configuration that caused the server to melt down. Yet the psychiatric team chose compliance with their own inherited paperwork over the reality of the patient's record.

The Mother's Protocol: A Missing Baseline

The most reliable diagnostic tool in Kelly's entire case file did not come from a physician or a clinical registry. It was his mother's persistent questioning. She kept asking where the anxiety was coming from. She was not a clinician, but she held the true operational baseline of the patient. She knew he was naturally optimistic. She knew he had never been depressed.

In compliance, we call this the baseline state. You cannot measure a system drift if you do not know what the system looked like when it was healthy. The DSM checklist has no room for this baseline. Gary Greenberg, in The Book of Woe, calls the DSM an "anthology of suffering"—a directory of how people hurt, not a map of why. Historian Anne Harrington has argued in Mind Fixers that modern biological psychiatry has overreached and overmedicated, completely replacing the individual's history with a checklist of symptoms.

When we label a person based purely on temporary emotional states, we ignore the physical state of the organism. Depressive despair has real somatic roots; emotional hopelessness can accelerate biological aging all the way down to immune-cell clocks, as explained on Cellular Aging as a Signature for the Emotional Side of Depression. By cataloging emotions without checking the body's physical and biological baseline, clinicians misidentify systemic failure as a simple software bug.

Rebuilding the Intake System

If we want to fix this, we have to change the psychiatric intake protocol. We need a strict verification gate. Before any clinician writes a prescription for an antidepressant or an antipsychotic, there must be a mandatory battery of laboratory screenings. We must check for thyroid dysfunction, metabolic imbalances, and infectious diseases like syphilis. It has to be non-negotiable.

We are beginning to develop highly sophisticated tools for precision psychiatry. For example, clinicians can now use resting-state functional MRI scans to pinpoint individual targets for neuromodulation, significantly improving responses in treatment-resistant depression (Harnessing fMRI for Precision TMS: Improving Depression Outcomes Beyond Scalp Targets). But these precision technologies are useless if we skip the basic, low-tech steps. What good is an fMRI scan if we fail to run a simple, ten-dollar blood test for a bacterial infection?

Psychiatry must stop treating the mind as a disembodied entity. The brain is an organ, supported by blood vessels, hormones, and an immune system. Until we audit the physical substrate of mental suffering, we will keep handing patients diagnostic coats that do not fit. We will keep letting the real causes of their pain escape detection.

More blogs